mRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance

[1]  Andrew Simmons,et al.  Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor. , 2014, Journal of Alzheimer's disease : JAD.

[2]  G. Riedel,et al.  Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration , 2014, Cellular and Molecular Life Sciences.

[3]  M. Ohno,et al.  Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice , 2014, The Journal of Neuroscience.

[4]  A. Lleó,et al.  Presenilin-1 influences processing of the acetylcholinesterase membrane anchor PRiMA , 2014, Neurobiology of Aging.

[5]  R. Nussinov,et al.  Single mutations in tau modulate the populations of fibril conformers through seed selection. , 2014, Angewandte Chemie.

[6]  M. Zimmermann,et al.  Neuronal AChE splice variants and their non‐hydrolytic functions: redefining a target of AChE inhibitors? , 2013, British journal of pharmacology.

[7]  R. Hortigüela,et al.  Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice , 2013, Neurobiology of Aging.

[8]  F. Campoy,et al.  The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency. , 2013, Chemico-biological interactions.

[9]  P. Ascher,et al.  Near‐complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase , 2012, Journal of neurochemistry.

[10]  D. Small,et al.  Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice , 2012, Neurobiology of Aging.

[11]  A. Diaspro,et al.  Amyloid-β protein precursor regulates phosphorylation and cellular compartmentalization of microtubule associated protein tau. , 2012, Journal of Alzheimer's disease : JAD.

[12]  L. Buée,et al.  Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology? , 2011, Current Alzheimer research.

[13]  T. Arendt,et al.  The cholinergic system in aging and neuronal degeneration , 2011, Behavioural Brain Research.

[14]  E. Mufson,et al.  Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice , 2011, Neurobiology of Disease.

[15]  Z. Henderson,et al.  Co-localization of PRiMA with acetylcholinesterase in cholinergic neurons of rat brain: An immunocytochemical study , 2010, Brain Research.

[16]  M. Das,et al.  Coexpression of glutamate vesicular transporter (VGLUT1) and choline acetyltransferase (ChAT) proteins in fetal rat hippocampal neurons in culture , 2010, In Vitro Cellular & Developmental Biology - Animal.

[17]  J. Jordán,et al.  Cholinesterase activity in brain of senescence‐accelerated‐resistant mouse SAMR1 and its variation in brain of senescence‐accelerated‐prone mouse SAMP8 , 2010, Journal of neuroscience research.

[18]  D. Teplow,et al.  Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[19]  Xiao-Jiang Sun,et al.  Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice , 2009, Neuroscience Letters.

[20]  S. Hamada,et al.  In situ hybridization study of the distribution of choline acetyltransferase mRNA and its splice variants in the mouse brain and spinal cord , 2009, Neuroscience.

[21]  T. Ben-Hur,et al.  A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics , 2008, Experimental Neurology.

[22]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[23]  L. Buée,et al.  P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.

[24]  H. Soreq,et al.  Virtues and woes of AChE alternative splicing in stress-related neuropathologies , 2006, Trends in Neurosciences.

[25]  M. Hasegawa,et al.  Phosphorylation of FTDP-17 Mutant tau by Cyclin-dependent Kinase 5 Complexed with p35, p25, or p39* , 2005, Journal of Biological Chemistry.

[26]  Michel Goedert,et al.  Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.

[27]  J. Mallet,et al.  Expression of PRiMA in the mouse brain: membrane anchoring and accumulation of ‘tailed’ acetylcholinesterase , 2003, The European journal of neuroscience.

[28]  J. Massoulie.  The Origin of the Molecular Diversity and Functional Anchoring of Cholinesterases , 2002, Neurosignals.

[29]  A. Delacourte,et al.  Functional Characterization of FTDP-17 tau Gene Mutations through Their Effects on Xenopus Oocyte Maturation* , 2002, The Journal of Biological Chemistry.

[30]  M. Goedert,et al.  Reduced Binding of Protein Phosphatase 2A to Tau Protein with Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Mutations , 2000, Journal of neurochemistry.

[31]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.